# Essure Transvaginal Ultrasound (TVU) Study

> **NCT01327105** · PHASE4 · COMPLETED · sponsor: **Bayer** · enrollment: 547 (actual)

## Conditions studied

- Contraceptive Usage

## Interventions

- **DEVICE:** TVU

## Key facts

- **NCT ID:** NCT01327105
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05-17
- **Primary completion:** 2014-07-16
- **Final completion:** 2023-07-04
- **Target enrollment:** 547 (ACTUAL)
- **Last updated:** 2023-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01327105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01327105, "Essure Transvaginal Ultrasound (TVU) Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01327105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*